Bullboard Post History

by malibuki

Order by:

V.SBM	RE:RE:Come on everything is the same after years I did not find anything. Is not it crystal clear? This supposed to be the... June 13, 2022
V.SBM	Come on everything is the same after years Old boarfers may remember me. I was around and trying to get in touch with... June 13, 2022
V.SBM	RE:RE:RE:Where is the peer review report of 1067? Sure things take time. Like half decade to have a tiny clinical trial, which... August 5, 2019
V.SBM	Where is the peer review report of 1067? Ages ago they mentioned release of trial data with a peer review article... August 2, 2019
V.SBM	A question Do you think there would be any PR if NA company decide to use or not the... March 7, 2019
V.SBM	RE:RE:News out Well in my comment I assumed the "Chinese cosmetic distribution company... February 26, 2019
V.SBM	RE:News out News indicate that current Chinese partner will not buy the asset but rather... February 26, 2019
V.SBM	RE:News misinterpreted? There is no misinterpretation. 1067 has much lower concentration compared to... February 22, 2019
V.SBM	Formulation I wonder how they prepared the current trial formulation. It seems parameters... February 13, 2019
V.SBM	RE:RE:I wait patiently...still I would say sglt2 inhibitor would work in cats. Here is a very recent... February 12, 2019
V.SBM	RE:RE:RE:RE:RE:RE:RE:RE:RE:January 2019 investor presentation This is my favorite, when I am right people begin personal attacks, it is... February 2, 2019
V.SBM	RE:RE:RE:RE:RE:RE:RE:January 2019 investor presentation Putin, Toxicity and skin lightenining effciency are two opposite... February 2, 2019
V.SBM	RE:RE:RE:RE:RE:January 2019 investor presentation I raised the issue of the positive control in NA trial loong ago and Wex said... February 1, 2019
V.SBM	about the update From the scientific point of view, I think the following is important "... January 30, 2019
V.SBM	Again issues with 1067 trial design They did not give details about the trial design and it is not clear if they... December 11, 2018
V.SBM	Sirona Biochem's SGLT2 Inhibitor in Testing for Animal Healt Vancouver, British Columbia – December 11, 2018 – Sirona Biochem... December 11, 2018
V.SBM	RE:Antifreeze Proteins Market -> USD 17.3 billion by 2025 There are many antifreeze molecules around. To be able to have a market share... November 20, 2018
V.SBM	1067 trial details I am really curious if they will have a positive control in the trial with an... November 20, 2018
V.SBM	Sirona Biochem Begins Proof of Efficacy Clinical Trial... Vancouver, British Columbia – November 6, 2018 – Sirona Biochem... November 6, 2018
V.SBM	new wingman Trying to conclude just around the corner deal for more than 5 years and now... October 19, 2018

Become a member today, It's free!

Bullboard Post History

by malibuki

RE:RE:Come on everything is the same after years

Come on everything is the same after years

RE:RE:RE:Where is the peer review report of 1067?

Where is the peer review report of 1067?

A question

RE:RE:News out

RE:News out

RE:News misinterpreted?

Formulation

RE:RE:I wait patiently...still

RE:RE:RE:RE:RE:RE:RE:RE:RE:January 2019 investor presentation

RE:RE:RE:RE:RE:RE:RE:January 2019 investor presentation

RE:RE:RE:RE:RE:January 2019 investor presentation

about the update

Again issues with 1067 trial design

Sirona Biochem's SGLT2 Inhibitor in Testing for Animal Healt

RE:Antifreeze Proteins Market -> USD 17.3 billion by 2025

1067 trial details

Sirona Biochem Begins Proof of Efficacy Clinical Trial...

new wingman

Featured Company

Copper Lake Resources Ltd. V.CPL

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by malibuki

Featured Company